{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T05:13:09Z","timestamp":1772255589825,"version":"3.50.1"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The advent of improved biomarkers promises to enhance the clinical care for patients with rheumatoid arthritis (RA) and other immune-mediated disorders. We have developed an innovative approach to broadly assess the cytokine responsiveness of human PBMCs using a multistimulant panel and multiplexed immunoassays. The objective of this study was to demonstrate this concept by determining whether cytokine profiles could discriminate RA patients according to disease stage (early versus late) or severity. A 10-cytokine profile, consisting of IL-12, CCL4, TNF-\u03b1, IL-4, and IL-10 release in response to stimulation with anti-CD3\/anti-CD28, CXCL8 and IL-6 in response to CMV and EBV lysate, and IL-17A, GM-CSF, and CCL2 in response to human heat shock protein 60, easily discriminated the early RA group from controls. These data were used to create an immune response score, which performed well in distinguishing the early RA patients from controls and also correlated with several markers of disease severity among the patients with late RA. In contrast, the same 10-cytokine profile assessed in serum was far less effective in discriminating the groups. Thus, our approach lays the foundation for the development of immunologic \u201csignatures\u201d that could be useful in predicting disease course and monitoring the outcomes of therapy among patients with immune-mediated diseases.<\/jats:p>","DOI":"10.4049\/jimmunol.0904180","type":"journal-article","created":{"date-parts":[[2010,5,21]],"date-time":"2010-05-21T21:11:10Z","timestamp":1274476270000},"page":"7297-7304","source":"Crossref","is-referenced-by-count":35,"title":["Analysis of Complex Biomarkers for Human Immune-Mediated Disorders Based on Cytokine Responsiveness of Peripheral Blood Cells"],"prefix":"10.1093","volume":"184","author":[{"suffix":"III","given":"John M","family":"Davis","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith L","family":"Knutson","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A","family":"Strausbauch","sequence":"additional","affiliation":[{"name":"Department of Surgical Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia S","family":"Crowson","sequence":"additional","affiliation":[{"name":"Division of Biomedical Statistics and Informatics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry M","family":"Therneau","sequence":"additional","affiliation":[{"name":"Division of Biomedical Statistics and Informatics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J","family":"Wettstein","sequence":"additional","affiliation":[{"name":"Department of Surgical Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric L","family":"Matteson","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherine E","family":"Gabriel","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine"},{"name":"Division of Epidemiology, Department of Health Sciences Research, College of Medicine, Mayo Clinic , Rochester, MN 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,6,15]]},"reference":[{"key":"2026012806323059900_r1","first-page":"4","article-title":"Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidence.","volume":"81","author":"Cohen","year":"2008","journal-title":"J. Rheumatol. Suppl."},{"key":"2026012806323059900_r2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3899\/jrheum.090131","article-title":"Unmet needs in rheumatoid arthritis.","volume":"82","author":"Bykerk","year":"2009","journal-title":"J. Rheumatol. Suppl."},{"key":"2026012806323059900_r3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/ar2418","article-title":"The need for prognosticators in rheumatoid arthritis: biological and clinical markers: where are we now?","volume":"10","author":"Smolen","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"2026012806323059900_r4","first-page":"1674","article-title":"Assessment of pain in rheumatoid arthritis: minimal clinically significant difference, predictors, and the effect of anti-tumor necrosis factor therapy.","volume":"34","author":"Wolfe","year":"2007","journal-title":"J. Rheumatol."},{"key":"2026012806323059900_r5","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/ard.60.10.956","article-title":"Benchmarking: the five year outcome of rheumatoid arthritis assessed using a pain score, the Health Assessment Questionnaire, and the Short Form-36 (SF-36) in a community and a clinic based sample.","volume":"60","author":"Wiles","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"2026012806323059900_r6","first-page":"1298","article-title":"The assessment and prediction of functional disability in rheumatoid arthritis.","volume":"18","author":"Wolfe","year":"1991","journal-title":"J. Rheumatol."},{"key":"2026012806323059900_r7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/ard.2008.090019","article-title":"Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade.","volume":"68","author":"Smolen","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"2026012806323059900_r8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/ard.62.8.722","article-title":"Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years.","volume":"62","author":"Turesson","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"2026012806323059900_r9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/art.10705","article-title":"Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years.","volume":"48","author":"Gabriel","year":"2003","journal-title":"Arthritis Rheum."},{"key":"2026012806323059900_r10","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/art.22895","article-title":"Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis.","volume":"57","author":"Wolfe","year":"2007","journal-title":"Arthritis Rheum."},{"key":"2026012806323059900_r11","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1002\/art.23945","article-title":"An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis.","volume":"58","author":"Brown","year":"2008","journal-title":"Arthritis Rheum."},{"key":"2026012806323059900_r12","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis.","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"2026012806323059900_r13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1253\/circj.CJ-09-0274","article-title":"Rheumatoid arthritis: model of systemic inflammation driving atherosclerosis.","volume":"73","author":"Ku","year":"2009","journal-title":"Circ. J."},{"key":"2026012806323059900_r14","first-page":"133","article-title":"Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells.","volume":"10","author":"de Jager","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"2026012806323059900_r15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"2026012806323059900_r16","first-page":"210","article-title":"Regulation of helper T cell responses to staphylococcal superantigens.","volume":"12","author":"Cameron","year":"2001","journal-title":"Eur. Cytokine Netw."},{"key":"2026012806323059900_r17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1089\/vim.2004.17.445","article-title":"CMV antigen-specific CD4+ and CD8+ T cell IFN\u03b3 expression and proliferation responses in healthy CMV-seropositive individuals.","volume":"17","author":"Sinclair","year":"2004","journal-title":"Viral Immunol."},{"key":"2026012806323059900_r18","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.transproceed.2004.05.032","article-title":"T-helper and T-cytotoxic cell subsets monitoring during active cytomegalovirus infection in liver transplantation.","volume":"36","author":"Wang","year":"2004","journal-title":"Transplant. Proc."},{"key":"2026012806323059900_r19","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1128\/JVI.77.8.4588-4596.2003","article-title":"Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2.","volume":"77","author":"Compton","year":"2003","journal-title":"J. Virol."},{"key":"2026012806323059900_r20","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1073\/pnas.0400525101","article-title":"Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection.","volume":"101","author":"Tabeta","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2026012806323059900_r21","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/eji.200425218","article-title":"Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.","volume":"34","author":"Rutz","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"2026012806323059900_r22","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1016\/j.febslet.2007.04.044","article-title":"Extracellular heat shock proteins in cell signaling.","volume":"581","author":"Calderwood","year":"2007","journal-title":"FEBS Lett."},{"key":"2026012806323059900_r23","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.4049\/jimmunol.175.6.3594","article-title":"Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway.","volume":"175","author":"Cohen-Sfady","year":"2005","journal-title":"J. Immunol."},{"key":"2026012806323059900_r24","doi-asserted-by":"crossref","first-page":"31332","DOI":"10.1074\/jbc.M103217200","article-title":"Endocytosed HSP60s use Toll-like receptor 2 (TLR2) and TLR4 to activate the Toll\/interleukin-1 receptor signaling pathway in innate immune cells.","volume":"276","author":"Vabulas","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2026012806323059900_r25","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1172\/JCI28423","article-title":"Heat shock protein 60 enhances CD4+CD25+ regulatory T cell function via innate TLR2 signaling.","volume":"116","author":"Zanin-Zhorov","year":"2006","journal-title":"J. Clin. Invest."},{"key":"2026012806323059900_r26","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.autrev.2008.12.004","article-title":"Heat-shock proteins can promote as well as regulate autoimmunity.","volume":"8","author":"Rajaiah","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"2026012806323059900_r27","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im0312s60","article-title":"Proliferative assays for T cell function.","volume-title":"Curr. Protoc. Immunol.","author":"Kruisbeek","year":"2004"},{"key":"2026012806323059900_r28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2004.04.028","article-title":"Optimum culture conditions for specific and nonspecific activation of whole blood and PBMC for intracellular cytokine assessment by flow cytometry.","volume":"292","author":"Godoy-Ramirez","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"2026012806323059900_r29","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood-2003-12-4395","article-title":"Peripheral CD4+CD8+ T cells are differentiated effector memory cells with antiviral functions.","volume":"104","author":"Nascimbeni","year":"2004","journal-title":"Blood"},{"key":"2026012806323059900_r30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"CpG motifs in bacterial DNA and their immune effects.","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"2026012806323059900_r31","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3462-1","volume-title":"Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis.","author":"Harrell","year":"2001"},{"key":"2026012806323059900_r32","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis.","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"2026012806323059900_r33","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1172\/JCI36389","article-title":"Evidence that cytokines play a role in rheumatoid arthritis.","volume":"118","author":"Brennan","year":"2008","journal-title":"J. Clin. Invest."},{"key":"2026012806323059900_r34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination.","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum."},{"key":"2026012806323059900_r35","doi-asserted-by":"crossref","first-page":"e7711","DOI":"10.1371\/journal.pone.0007711","article-title":"Determinants of the relationship between cytokine production in pregnant women and their infants.","volume":"4","author":"Djuardi","year":"2009","journal-title":"PLoS One"},{"key":"2026012806323059900_r36","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar1020","article-title":"Decreased response to IL-12 and IL-18 of peripheral blood cells in rheumatoid arthritis.","volume":"6","author":"Kawashima","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"2026012806323059900_r37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/ard.60.2.133","article-title":"Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNF\u03b1 receptors.","volume":"60","author":"Berg","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"2026012806323059900_r38","first-page":"584","article-title":"Multiplex serum cytokine monitoring as a prognostic tool in rheumatoid arthritis.","volume":"25","author":"Alex","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"key":"2026012806323059900_r39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ibd.20753","article-title":"Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis.","volume":"15","author":"Alex","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"2026012806323059900_r40","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/prca.200780095","article-title":"Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases.","volume":"2","author":"Linkov","year":"2008","journal-title":"Proteomics Clin. Appl."},{"key":"2026012806323059900_r41","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/bcr2096","article-title":"Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer.","volume":"10","author":"Nolen","year":"2008","journal-title":"Breast Cancer Res."},{"key":"2026012806323059900_r42","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.1780391204","article-title":"Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis.","volume":"39","author":"Dolhain","year":"1996","journal-title":"Arthritis Rheum."},{"key":"2026012806323059900_r43","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/eji.1830250612","article-title":"Altered T lymphocyte signaling in rheumatoid arthritis.","volume":"25","author":"Allen","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"2026012806323059900_r44","first-page":"1466","article-title":"Analysis of type 1 and type 2 T cells in synovial fluid and peripheral blood of patients with rheumatoid arthritis.","volume":"25","author":"Kusaba","year":"1998","journal-title":"J. Rheumatol."},{"key":"2026012806323059900_r45","first-page":"1128","article-title":"Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.","volume":"27","author":"Berner","year":"2000","journal-title":"J. Rheumatol."},{"key":"2026012806323059900_r46","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1046\/j.1365-2567.2000.00966.x","article-title":"Relationship between disease severity and responses by blood mononuclear cells from patients with rheumatoid arthritis to human heat-shock protein 60.","volume":"99","author":"MacHt","year":"2000","journal-title":"Immunology"},{"key":"2026012806323059900_r47","doi-asserted-by":"crossref","first-page":"132732","DOI":"10.1155\/2008\/132732","article-title":"Increased responsiveness to Toll-like receptor 4 stimulation in peripheral blood mononuclear cells from patients with recent onset rheumatoid arthritis.","volume":"2008","author":"Kowalski","year":"2008","journal-title":"Mediators Inflamm."},{"key":"2026012806323059900_r48","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3109\/03009749509095182","article-title":"Production of TNF by monocytes of patients with early rheumatoid arthritis is increased.","volume":"24","author":"Leirisalo-Repo","year":"1995","journal-title":"Scand. J. Rheumatol."},{"key":"2026012806323059900_r49","first-page":"998","article-title":"Mononuclear cell response to lipopolysaccharide in patients with rheumatoid arthritis: relationship with tristetraprolin expression.","volume":"32","author":"Fabris","year":"2005","journal-title":"J. Rheumatol."},{"key":"2026012806323059900_r50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/s10165-007-0015-y","article-title":"Interleukin-17 gene expression in patients with rheumatoid arthritis.","volume":"18","author":"Kohno","year":"2008","journal-title":"Mod. Rheumatol."},{"key":"2026012806323059900_r51","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/ard.2004.022731","article-title":"Effect of treatment of rheumatoid arthritis with infliximab on IFN \u03b3, IL4, T-bet, and GATA-3 expression: link with improvement of systemic inflammation and disease activity.","volume":"64","author":"Kawashima","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"2026012806323059900_r52","first-page":"496","article-title":"Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment.","volume":"28","author":"Seitz","year":"2001","journal-title":"J. Rheumatol."},{"key":"2026012806323059900_r53","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jim.2005.03.009","article-title":"Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies.","volume":"300","author":"de Jager","year":"2005","journal-title":"J. Immunol. Methods"},{"key":"2026012806323059900_r54","first-page":"2336","article-title":"A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis.","volume":"31","author":"Hitchon","year":"2004","journal-title":"J. Rheumatol."},{"key":"2026012806323059900_r55","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/ard.2006.054924","article-title":"Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines.","volume":"66","author":"Hueber","year":"2007","journal-title":"Ann. Rheum. Dis."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/184\/12\/7297\/62722755\/ji_0904180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/184\/12\/7297\/62722755\/ji_0904180.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:36:09Z","timestamp":1769600169000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/184\/12\/7297\/8007223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":55,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2010,6,15]]},"published-print":{"date-parts":[[2010,6,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.0904180","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.5934957.5932055","asserted-by":"object"}]},"ISSN":["1550-6606","0022-1767"],"issn-type":[{"value":"1550-6606","type":"electronic"},{"value":"0022-1767","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,6]]},"published":{"date-parts":[[2010,6]]}}}